SCHEMBL25826451

SCHEMBL25826451

Cc1cc(Cc2ccc([N+](=O)[O-])c(N)n2)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 5/20 0.37
TSHR P16473 2/20 0.37
CYP3A4 P08684 1/20 0.37
RECQL P46063 1/20 0.37
MAPT P10636 4/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
PDE4D Q08499 1/20 0.35
PDE4B Q07343 1/20 0.35
CTSB P07858 1/20 0.35
CTSH P09668 1/20 0.35
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826450 0.87 SMN1; SMN2 (0.37) MEN1KMT2ASMN1; SMN2ALDH1A1TSHR
SCHEMBL28081097 0.81 TSHR (0.44) MEN1KMT2ASMN1; SMN2ALDH1A1TSHR
SCHEMBL25826448 0.79 UHRF1 (0.36)
SCHEMBL25826364 0.77 TSHR (0.50) MEN1KMT2ASMN1; SMN2ALDH1A1TSHR
SCHEMBL11236516 0.75 MAP4K4 (0.51) MEN1KMT2ASMN1; SMN2ALDH1A1RECQL
SCHEMBL26310311 0.73 ROCK1 (0.47) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL111594 0.73 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL29868909 0.73 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4RECQLMAPT
SCHEMBL25826365 0.72 SMN1; SMN2 (0.37) MEN1KMT2ASMN1; SMN2ALDH1A1TSHR
SCHEMBL12727962 0.71 POLB (0.63) MEN1KMT2ASMN1; SMN2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MEN1 1948/4885KMT2A 3974/4885SMN1; SMN2 2070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.